Compounds by Use

Compounds associated with Use entry: Cytotoxic activity on HL-60 leukemia cells

SANCDB ID		Name	select all
		3[beta],16[beta],17[alpha]-trihydroxycholest-5-en-22-one 16-O-(2-O-4-methoxybenzoyl-[beta]P-d-xylopyranosyl)-(1[to]3)-(2-O-acetyl-[alpha]-l-arabinopyranoside)
		(22S)-3[beta]-[([beta]-D-glucopyranosyl)oxy]-22-hydroxycholesta-5,24-dien-16[beta]-yl 3-O-acetyl-[alpha]-L-rhamnopyranoside
		(25R)-3[beta]-Hydroxyspirost-5-en-1[beta]-yl O-[alpha]-l-rhamnopyranosyl-(1[to]2)-O-[[beta]-D-xylopyranosyl-(1[to]3)]-[alpha]-L-arabinopyranoside
		(22S)-16[beta]-[([beta]-D-glucopyranosyl)oxy]-3[beta],22-dihydroxy-5[alpha]-cholestan-1[beta]-yl 6-O-(3,4,5-trimethoxybenzoyl)-[beta]-D-glucopyranoside
		(25R)-3[beta]-hydroxy-5[alpha]-spirostan-1[beta]-yl [beta]-D-glucopyranoside
		24S,25S)-3[beta],24-dihydroxyspirost-5-en-1[beta]-yl O-[alpha]- L-rhamnospyranosyl-(1[to]2)-[alpha]-L-arabinopyranoside
		3[beta]-[([beta]-D-glucopyranosyl)oxy]-17[alpha]-hydroxy-16[beta]-[(O-(2-O-3,4-dimethoxybenzoyl-[beta]-D-xylopyranosyl)-(1[to]2)-2-O-acetyl-[alpha]-L-arabinopyranosyl)oxy]cholest-5-en-22-one
		3[beta]-[([beta]-D-glucopyranosyl)oxy]-17[alpha]-hydroxy-16[beta]-[(O-[beta]-D-xylopyranosyl-(1[to]2)-2-O-acetyl-[alpha]-L-arabinopyranosyl)oxy]cholest-5-en-22-one
		16[beta]-[([alpha]-L-arabinopyranosyl)oxy]-3[beta]-[([beta]-D-glucopyranosyl)oxy]-17[alpha]-hydroxycholest-5-en-22-one
		3[beta],17[alpha]-dihydroxy-16[beta]-[(O-[beta]-D-glucopyranosyl-(1[to]4)-O-(2-O-3,4-dimethoxybenzoyl-[beta]-D-xylopyranosyl)-(1[to]3)-2-O-acetyl-[alpha]-L-arabinopyranosyl)oxy]cholest-5-en-22-one
		3[beta],17[alpha]-dihydroxy-16[beta]-[(O-[beta]-D-glucopyranosyl-(1[to]4)-O-(2-O-3,4,5-trimethoxybenzoyl-[beta]-D-xylopyranosyl)-(1[to]3)-2-O-acetyl-[alpha]-L-arabinopyranosyl)oxy]cholest-5-en-22-one
		3[beta]-[([beta]-D-glucopyranosyl)oxy)]-17[alpha]-hydroxy-16[beta]-[(O-(2-O-3,4,5-trimethoxybenzoyl-[beta]-D-xylopyranosyl)-(1[to]3)-2-O-acetyl-[alpha]-L-arabinopyranosyl)oxy]cholest-5-en-22-one
		3[beta]-[(O-[beta]-D-Glucopyranosyl-(1[to]6)-[beta]-D-glucopyranosyl)oxy)]-17[alpha]-hydroxy-16[beta]-[(O-(2-O-3,4-dimethoxybenzoyl-[beta]-D-xylopyranosyl)-(1[to]3)-2-O-acetyl-[alpha]-L-arabinopyranosyl)oxy]cholest-5-en-22-one
		3[beta]-[(O-[beta]-D-glucopyranosyl-(1[to]6)-[beta]-D-glucopyranosyl)oxy)]-17[alpha]-hydroxy-16[beta]-[(O-(2-O-3,4,5-trimethoxybenzoyl-[beta]-D-xylopyranosyl)-(1[to]3)-2-O-acetyl-[alpha]-L-arabinopyranosyl)oxy]cholest-5-en-22-one
		3[beta]-[(O-[beta]-D-glucopyranosyl-(1[to]4)-O-[beta]-D-glucopyranosyl-(1[to]6)-[beta]-D-glucopyranosyl)oxy)]-17[alpha]-hydroxy-16[beta]-[(O-(2-O-3,4,5-trimethoxybenzoyl-[beta]-D-xylopyranosyl)-(1[to]3)-2-O-acetyl-[alpha]-L-arabinopyranosyl)oxy]cholest...
		3[beta]-[(O-[beta]-D-glucopyranosyl-(1[to]4)-O-[beta]-D-glucopyranosyl-(1[to]6)-[beta]-D-glucopyranosyl)oxy)]-17[alpha]-hydroxy-16[beta]-[(O-(3-O-3,4-dimethoxybenzoyl-[beta]-D-xylopyranosyl)-(1[to]3)-2-O-acetyl-[alpha]-L-arabinopyranosyl)oxy]cholest-5...
		3[beta],16[beta],17[alpha]-trihydroxycholest-5-en-22-one 3-O-[beta]-D-glucopyranoside 16-O-{O-(2-E-cinnamoyl-[beta]-D-xyopyranosyl)-(1[to]3)-2-O-acetyl-[alpha]-L-arabinopyranoside}
		(25R)-3[beta]-hydroxyspirost-5-en-1[beta]-yl O-[alpha]-L-rhamnopyranosyl-(1[to]2)-[alpha]-L-arabinopyranoside
		(22S)-16[beta]-[(6-O-acetyl-[beta]-D-glucopyranosyl)oxy]-3[beta],22-dihydroxy-5[alpha]-cholestan-1[beta]-yl [alpha]-L-rhamnopyranoside
		(22S)-16[beta]-[([alpha]-L-rhamnopyranosyl)oxy]-3[beta],22-dihydroxycholesta-5,24-dien-1[beta]-yl [alpha]-L-rhamnopyranoside
		3[beta]-[(O-[beta]-D-Glucopyranosyl-(1[to]4)-O-[beta]-D-glucopyranosyl-(1[to]6)-[beta]-D-glucopyranosyl)oxy)]-17[alpha]-hydroxy-16[beta]-[(O-(2-O-3,4-dimethoxybenzoyl-[beta]-D-xylopyranosyl)-(1[to]3)-2-O-acetyl-[alpha]-L-arabinopyranosyl)oxy]cholest-5-...

Compounds associated with Use entry: Cytotoxic activity on HL-60 leukemia cells

Quick search

Sign In

Update Password